These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8800399)

  • 1. A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence: adjunctive pharmacotherapy during and after inpatient treatment.
    Kabel DI; Petty F
    Alcohol Clin Exp Res; 1996 Jun; 20(4):780-4. PubMed ID: 8800399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine attenuates alcohol intake and desire to drink.
    Naranjo CA; Poulos CX; Bremner KE; Lanctot KL
    Int Clin Psychopharmacol; 1994 Sep; 9(3):163-72. PubMed ID: 7814825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fluoxetine on alcohol consumption in male alcoholics.
    Gorelick DA; Paredes A
    Alcohol Clin Exp Res; 1992 Apr; 16(2):261-5. PubMed ID: 1317133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
    Davey CG; Chanen AM; Hetrick SE; Cotton SM; Ratheesh A; Amminger GP; Koutsogiannis J; Phelan M; Mullen E; Harrison BJ; Rice S; Parker AG; Dean OM; Weller A; Kerr M; Quinn AL; Catania L; Kazantzis N; McGorry PD; Berk M
    Lancet Psychiatry; 2019 Sep; 6(9):735-744. PubMed ID: 31371212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment approaches to major depressive disorder relapse. Part 2: reinitiation of antidepressant treatment.
    Fava M; Schmidt ME; Zhang S; Gonzales J; Raute NJ; Judge R
    Psychother Psychosom; 2002; 71(4):195-9. PubMed ID: 12097784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of fluoxetine in crack cocaine dependence.
    Batki SL; Washburn AM; Delucchi K; Jones RT
    Drug Alcohol Depend; 1996 Jun; 41(2):137-42. PubMed ID: 8809502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study.
    Chen Y; Cao X; Zang W; Tan S; Ou CQ; Shen X; Gao T; Zhao L
    Trials; 2019 Jan; 20(1):34. PubMed ID: 30626424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics.
    Kranzler HR; Burleson JA; Korner P; Del Boca FK; Bohn MJ; Brown J; Liebowitz N
    Am J Psychiatry; 1995 Mar; 152(3):391-7. PubMed ID: 7864265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa.
    Kaye WH; Nagata T; Weltzin TE; Hsu LK; Sokol MS; McConaha C; Plotnicov KH; Weise J; Deep D
    Biol Psychiatry; 2001 Apr; 49(7):644-52. PubMed ID: 11297722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment approaches to major depressive disorder relapse. Part 1: dose increase.
    Schmidt ME; Fava M; Zhang S; Gonzales J; Raute NJ; Judge R
    Psychother Psychosom; 2002; 71(4):190-4. PubMed ID: 12097783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial.
    Cornelius JR; Salloum IM; Ehler JG; Jarrett PJ; Cornelius MD; Perel JM; Thase ME; Black A
    Arch Gen Psychiatry; 1997 Aug; 54(8):700-5. PubMed ID: 9283504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary report: double-blind, placebo-controlled study of fluoxetine in depressed alcoholics.
    Cornelius JR; Salloum IM; Cornelius MD; Perel JM; Ehler JG; Jarrett PJ; Levin RL; Black A; Mann JJ
    Psychopharmacol Bull; 1995; 31(2):297-303. PubMed ID: 7491382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fluoxetine at antidepressant doses on short-term outcome of detoxified alcoholics.
    Janiri L; Gobbi G; Mannelli P; Pozzi G; Serretti A; Tempesta E
    Int Clin Psychopharmacol; 1996 Jun; 11(2):109-17. PubMed ID: 8803648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of citalopram and fluoxetine on sexual behavior in healthy men: evidence of delayed ejaculation and unaffected sexual desire. A randomized, placebo-controlled, double-blind, double-dummy, parallel group study.
    Madeo B; Bettica P; Milleri S; Balestrieri A; Granata AR; Carani C; Rochira V
    J Sex Med; 2008 Oct; 5(10):2431-41. PubMed ID: 18410297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study.
    Cornelius JR; Salloum IM; Haskett RF; Daley DC; Cornelius MD; Thase ME; Perel JM
    Addict Behav; 2000; 25(2):307-10. PubMed ID: 10795957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder.
    Arnold LM; McElroy SL; Hudson JI; Welge JA; Bennett AJ; Keck PE
    J Clin Psychiatry; 2002 Nov; 63(11):1028-33. PubMed ID: 12444817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
    Waldinger MD; Hengeveld MW; Zwinderman AH; Olivier B
    J Clin Psychopharmacol; 1998 Aug; 18(4):274-81. PubMed ID: 9690692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence.
    Farren CK; Scimeca M; Wu R; Malley SO
    Drug Alcohol Depend; 2009 Jan; 99(1-3):317-21. PubMed ID: 18644685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder.
    Shapira NA; Ward HE; Mandoki M; Murphy TK; Yang MC; Blier P; Goodman WK
    Biol Psychiatry; 2004 Mar; 55(5):553-5. PubMed ID: 15023585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.